Health · Medical Research · 5 hrs ago
Continuous Glucose Monitors Lowered HbA1c in Adults With Type 2 Diabetes
A randomized trial called CONNECT studied continuous glucose monitoring in adults with type 2 diabetes who were not treated with insulin.
It included 283 patients at primary care practices.
A continuous glucose monitor tracks glucose levels over time.
The trial found that use of the monitors reduced HbA1c levels, a measure used to assess blood sugar.
The findings suggest this approach may help people with type 2 diabetes who do not use insulin.
The available information does not give the size of the reduction or say what happens next.
Use of continuous glucose monitors reduced HbA1c levels in adults with type 2 diabetes who were not treated with insulin.
The finding came from the randomized CONNECT trial.
The trial included 283 patients at primary care practices.
MedPage Today reported the findings on October 14, 2026.
- Who
- 283 adults with type 2 diabetes who were not treated with insulin.
- What
- The randomized CONNECT trial found that continuous glucose monitoring reduced HbA1c levels.
- When
- MedPage Today reported the findings on October 14, 2026. The trial dates are not stated.
- Where
- Primary care practices; a more specific location is not stated.
- Why
- Not stated
This story does not have two clearly opposing sides.
This story does not have a timeline yet.
- Trial
- CONNECT
- Participants
- 283 patients
- Condition
- Type 2 diabetes
- Treatment status
- Not treated with insulin
- Setting
- Primary care practices
- Reported
- October 14, 2026, by MedPage Today